4-氨基-3-羟基萘-1-磺酸钠 | 5959-58-0

• 物质功能分类: 化学试剂 - 有机试剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 4-氨基-3-羟基萘-1-磺酸钠
• 中文别名: (6R)-3-(乙酰氧基甲基)-7-甲氧基-8-羰基-7-(2-噻嗯基乙酰氨基)-5-硫杂-1-氮杂二环[4.2.0]辛-2-烯-2-羧酸
• CAS: 5959-58-0
• 化学式: C10H9NNaO4S
• 分子量: 262.24
• InChiKey: JXHXLNHOIAQJFL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.99
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  109
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES
  申请人：Dyomics GmbH

  公开号：US20150175591A1

  公开（公告）日：2015-06-25

  The invention concerns compounds based on benzoxazoles wherein selected substituents are each a reactive group A bound via a linker L and adapted to covalently bond a compound of the invention to a to-be-marked molecule K, wherein A is an amine, hydroxy or phosphoramidite function, a carboxylic acid, an alkyl or active ester derived therefrom; a carboxylic acid hydrazide; or a carboxylic acid amide where K is a covalently bound component selected from the group haptenes−, proteins (antibodies), low molecular weight drug compounds, peptides, nucleotides, nucleosides, DNA oligomers, polymers, and t is from 1 to 10, and L is a linker selected from a group featuring —(CH 2 ) s —, —[(CH 2 ) m —O] p —(CH 2 ) m —, —NR10-(CH 2 ) s —, —O—(CH 2 ) s —, —S—(CH 2 ) s —, —NR10-C(O)—(CH 2 ) s —, —NR10-C(O)—O—(CH 2 ) s —, —NR10-C(O)—NR11-(CH 2 ) s — or —SO 2 —NR10-(CH 2 ) s —, wherein R10 and R11 are each independently hydrogen, alkyl and alkoxy-alkyl (—[(CH 2 ) m —O] p —CH 3 ), ω-sulfoalkyl (—(CH 2 ) r —SO 3 ), m represents the numbers of 2-5, p, r and s each independently represent the number of 1-10.

  该发明涉及基于苯并噁唑的化合物，其中所选取的取代基分别是通过连接基L结合的反应性基团A，并适用于以共价键将该发明的化合物结合到待标记的分子K，其中A是胺基、羟基或磷酰胺基、羧酸、由此衍生的烷基或活性酯；羧酸肼；或羧酸酰胺，其中K是从半抗原、蛋白质（抗体）、低分子量药物化合物、肽、核苷酸、核苷、DNA寡聚物、聚合物中选择的共价结合组分，t为1至10，L是从特征为—(CH2)s—、—[( )m—O]p—( )m—、—NR10-( )s—、—O—( )s—、—S—( )s—、—NR10-C(O)—( )s—、—NR10-C(O)—O—( )s—、—NR10-C(O)—NR11-( )s—或—SO2—NR10-( )s—的一组中选择的连接基，其中R10和R11各自独立地是氢、烷基和烷氧基烷基（—[( )m—O]p—CH3）、ω-磺酰基烷基（—( )r—SO3），m代表2-5的数字，p、r和s各自独立地代表1-10的数字。
• PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES
  申请人：Italfarmaco, S.A.

  公开号：EP1602644A1

  公开（公告）日：2005-12-07

  A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10R11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.

  一种具有化学式（I）的萘磺酸或喹啉磺酸，其中A为N或CR8配方基团，其中R8为H、OH、NR10R11，独立地，其中R10和R11分别代表H或C1-C6烷基或配方NH-CO-R12的基团，其中R12为C1-C6烷基或C6-C10芳基；R1和R2独立地代表H或SO3R9，其中R9为H、铵或碱金属或碱土金属的阳离子；R3为H或OH；R4、R5、R6和R7独立地代表H、NR10R11或NH-CO-R12基团；条件是（i）R1或R2中至少有一个为SO3R9，（ii）R4、R5、R6或R7中至少有一个为NR10R11或NH-CO-R12基团，或它们的药用可接受盐；以及药用可接受的赋形剂。
• Pharmaceutical compositions containing sulphonic acid derivatives
  申请人：Banfi Tosi María Beatriz

  公开号：US20060160849A1

  公开（公告）日：2006-07-20

  A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR 8 formula group, where R 8 is H, OH, NR 10 R 11 , independently from one another, where R 10 and R 11 represent H or C 1 -C 6 alkyl or a group of formula NH—CO—R 12 , where R 12 is C 1 -C 6 alkyl or C 6 -C 10 aryl; R 1 and R 2 represent H or SO 3 R 9 , independently from one another, where R 9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R 3 is H or OH; and R 4 , R 5 , R 6 and R 7 represent H, an NR 10 R 11 or NH—CO—R 12 group, independently from one another; on the condition that (i) at least one of R 1 or R 2 is SO 3 R 9 , and (ii) at least one of R 4 , R 5 , R 6 or R 7 is an NR 10 R 11 or NH—CO—R 12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.

  公式（I）中的萘磺酸或喹啉磺酸，其中A为N或CR8配方基团，其中R8为H，OH，NR10R11，独立地，其中R10和R11代表H或C1-C6烷基或配方为NH-CO-R12的基团，其中R12为C1-C6烷基或C6-C10芳基；R1和R2独立地代表H或SO3R9，其中R9为H，铵离子或碱金属或碱土金属阳离子；R3代表H或OH；R4、R5、R6和R7独立地代表H，NR10R11或NH-CO-R12基团；条件是（i）R1或R2至少有一个为SO3R9，且（ii）R4、R5、R6或R7至少有一个为NR10R11或NH-CO-R12基团，或其药学上可接受的盐；以及药学上可接受的赋形剂。
• Carbon material
  申请人：Luthge Thomas

  公开号：US20070031319A1

  公开（公告）日：2007-02-08

  Carbon material having organic groups, obtainable by the reaction of carbon material with organic compounds of the general formula 1 The invention's carbon materials having organic groups are useful in dispersions, rubber, plastics, inks, including solventborne inks, waterborne inks, inkjet inks, xerographic toners, coatings, paints, bitumen, concrete or other building materials, paper or as a reducing agent in metallurgy.

  本发明提供了具有有机基团的碳材料，其可通过将碳材料与一般式1的有机化合物反应而得到。该发明的具有有机基团的碳材料可用于分散、橡胶、塑料、油墨（包括溶剂型油墨、水性油墨、喷墨油墨、静电复印机色调剂）、涂料、油漆、沥青、混凝土或其他建筑材料、纸张或作为冶金中的还原剂。
• EP1994929A1
  申请人：——

  公开号：EP1994929A1

  公开（公告）日：2008-11-26